Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Sayre Therapeutics
About
A healthcare organisation in the business of commercialising novel medicines, medical devices and molecular diagnostics in Oncology.
- 11 - 50
Highlights
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $1M
- Industries
- Biotechnology,Health Diagnostics,Medical Device,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
At Sayre Therapeutics, They focus on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists and rheumatologists.These include, but are not limited to, small molecules, recombinant proteins,monoclonal antibodies (mAbs),drug-delivery devices and diagnostics in Oncology and Immunology.Our business model encompasses Global access / early access programs, Named Patient programs and securing product registrations for exclusive commercial distribution in South Asia.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 4, 2017 | Debt Financing | $1M | 1 |
InnoVen Capital
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
InnoVen Capital
|
Yes | Debt Financing |
